Mrcpsych Syllabus
Mrcpsych Syllabus
Mrcpsych Syllabus
1.1
Basic Psychology
1.1.1 Learning theory: classical, operant, observational and cognitive
models. The concepts of extinction and reinforcement. Learning
processes and aetiological formulation of clinical problems, including
the concepts of generalisation, secondary reinforcement, incubation
and stimulus preparedness. Escape and avoidance conditioning.
Clinical applications in behavioural treatments: reciprocal inhibition,
habituation, chaining, shaping, cueing. The impact of various
reinforcement schedules. The psychology of punishment. Optimal
conditions for observational learning.
1.1.2 Basic principles of visual and auditory perception: figure ground
differentiation, object constancy, set, and other aspects of perceptual
organisation. Perception as an active process. The relevance of
perceptual
theory
to
illusions,
hallucinations
and
other
psychopathology. The development of visual perception as an
illustration of constitutional/ environmental interaction.
1.1.3 Information processing and attention. The application of these to the
study of schizophrenia and other conditions.
1.1.4 Memory: influences upon and optimal conditions for encoding,
storage and retrieval. Primary working memory storage capacity and
the principle of chunking. Semantic episodic and skills memories and
other aspects of long-term/secondary memory. The process of
forgetting. Emotional factors and retrieval. Distortion, inference,
schemata and elaboration in relation. The relevance of this to
memory disorders and their assessment.
1.1.5 Thought: the possible relationship with language. Concepts,
prototypes and cores. Deductive and inductive reasoning. Problemsolving strategies, algorithms and heuristics.
1.1.6 Personality: derivation of nomothetic and idiographic theories. Trait
and type approaches and elementary personal construct theory.
Resume of principles underlying psychoanalytic, social learning,
cognitive neuroscience and humanistic approaches. The interactionist
approach. Construction and use of inventories, rating scales, grids
and Q-sort.
1.1.7 Motivation: needs and drives. Extrinsic theories (based on primary
and secondary drive reduction) and homeostasis. Hypothalamic
systems and satiety. Intrinsic theories, curiosity and optimum levels
of arousal. Limitations of approach and attempts to integrate.
Page 1 of 24
Page 2 of 24
Page 3 of 24
2.
HUMAN DEVELOPMENT
2.2
2.3
2.4
2.5
2.6
2.7
2.8
2.9
2.10
2.11
2.12
2.13
2.14
2.15
2.16
2.17
2.18
Page 5 of 24
3. BASIC NEUROSCIENCES
The trainee shall demonstrate knowledge of basic neurosciences which
underpin the practice of clinical psychiatry.
3.1 Neuroanatomy
3.1.1 The general anatomy of the brain and the functions of the lobes and
some of the major gyri including the prefrontal cortex, cingulate gyrus
and limbic system. Basic knowledge of the cranial nerves and spinal
chord.
3.1.2 The anatomy of the basal ganglia.
3.1.3 The internal anatomy of the temporal lobes, i.e. hippocampal formation
and amygdala.
3.1.4 The major white matter pathways, e.g. corpus callosum, fornix, Papezs
circuit and other circuits relevant to integrated behaviour (see
neurophysiology section).
3.1.5 The types of cell found within the nervous system.
3.1.6 The major neurochemical pathways, including the nigrostriatal,
mesolimbic and mesocortical dopamine pathways, the ascending
noradrenergic pathway from the locus coeruleus, the basal forebrain
cholinergic pathway, the brain stem cholinergic pathway, the
corticofugal glutamate system and serotonin pathways.
3.2 Neurophysiology
3.2.1 The basic concepts in the physiology of neurones, synapses and
receptors, including synthesis, release and uptake of transmitters. A
basic knowledge of action potential, resting potential, ion fluxes and
channels etc.
3.2.2 The physiology and anatomical pathways of the neural and endocrine
systems involved in integrated behaviour including perception, pain,
memory, motor function, arousal, drives (sexual behaviour, hunger and
thirst), motivation and the emotions, including aggression, fear and
stress. Knowledge of disturbances of these functions with relevance to
organic and non-organic (functional) psychiatry.
3.2.3 The development and localisation of cerebral functions throughout the
life span from the foetal stages onwards and their relevance to the
effects of injury at different ages to the brain and to mental function. An
understanding of neurodevelopmental models of psychiatric disorders
and of cerebral plasticity.
3.2.4 An understanding of the neuroendocrine system, in particular the
control of the secretion of hypothalamic and pituitary hormones (by
releasing factors and by feedback control) and posterior pituitary
function. The main hormonal changes in psychiatric disorders. A basic
understanding of neuroendocrine rhythms and their disturbance in
psychiatric disorders.
3.2.5 A basic knowledge of the physiology of arousal and sleep and with
particular reference to noradrenergic activity and the locus coeruleus.
3.2.6 The normal EEG (including frequency bands) and evoked response
techniques. The applications to investigation of cerebral pathology,
seizure disorders, sleep and psychiatric disorders. The effects of drugs
on the EEG.
Page 6 of 24
3.3 Neurochemistry
3.3.1 Transmitter synthesis, storage and release. Ion channels and calcium
flux in relation to this.
3.3.2 Knowledge of receptor structure and function in relation to the
transmitters listed below. Pre-synaptic and post-synaptic receptors.
3.3.3 Basic pharmacology of noradrenaline, serotonin, dopamine, GABA,
acetylcholine, excitatory amino acids.
3.3.4 Elementary knowledge of neuropeptides, particularly corticotrophin
releasing hormone and cholecystokinin and the encephalins/endorphins.
3.4 Molecular Genetics
3.4.1 Basic concepts: chromosomes, cell division, gene structure,
transcription and translation, structure of the human genome, patterns
of inheritance.
3.4.2 Traditional techniques: family, twin and adoption studies.
3.4.3 Techniques in molecular genetics: restriction enzymes, molecular
cloning and gene probes, Southern blotting, restriction fragment length
polymorphisms, recombination.
3.4.4 Distinction between direct gene analysis and gene tracking. Genetic
markers, linkage studies, lod scores. Genome wide association studies,
genetic variants.
3.4.5 Conditions associated with chromosome abnormalities.
3.4.6 Principal inherited conditions encountered in psychiatric practice and the
genetic contribution to specific psychiatric disorders.
3.4.7 Prenatal identification. Genetic counselling. The organisation of clinical
genetic services, DNA banks.
3.4.8
Molecular and genetic heterogeneity. Phenotype/genotype
correspondence. Endophenotypes. Gene X Environment interaction.
Epigenetics
3.5 Neuropathology
3.5.1 Neuropathology of Dementia
3.5.1.1 Neuropathology of Alzheimers Disease
3.5.1.2 Neuropathology of Picks Disease and Fronto-Temporal Dementias
3.5.1.3 Neuropathology of Lewy Body diseases including Parknisons
Disease
3.5.2 Neuropathology of Prion Diseases
3.5.3 Neuropathology of HIV brain disease.
Page 7 of 24
4. CLINICAL PSYCHOPHARMACOLOGY
The trainee will demonstrate knowledge of psychopharmacology.
This knowledge will include will include pharmacological action,
clinical indications, side effects, drug interactions, toxicity and
appropriate prescribing practice. In particular trainees will be able
to demonstrate knowledge of:
4.1 General Principles
A brief historical overview of the development of psychotropic drugs. Their
classification. Optimising patient compliance. Knowledge of the placebo
effect and the importance of controlling for it. The principles of rational
prescribing of psychoactive drugs.
4.2 Pharmacokinetics
4.2.1 General principles of absorption, distribution, metabolism and
elimination. Drug interactions. Particular reference to a comparison
of oral, intramuscular and intravenous routes of administration as
they affect drug availability, elimination as it affects the life of the
drug in the body and access to the brain through the blood-brain
barrier. Applications of these to choice of administrative route and
timing of doses. The relationship of ageing, culture, ethnicity to
pharmacokinetics.
4.2.2 Relationships between plasma drug level and therapeutic response:
the possibilities and limitations of this concept with specific examples
such as lithium, antidepressants and anticonvulsants.
4.3 Pharmacodynamics
4.3.1 Synaptic receptor complexity, main receptor sub-types, phenomena
of receptor up- and down- regulation. Pharmacogenetics
4.3.2 The principal CNS pharmacology of the main groups of drugs used in
psychiatry with particular attention to their postulated modes of
action in achieving therapeutic affect: at both molecular/synaptic and
systems levels. These groups would include anti-psychotic agents,
drugs used in the treatment of affective disorder (both mood altering
and stabilising), anxiolytics, hypnotics and anti-epileptic agents. The
relationship of culture, race and ethnicity to pharmacodynamics.
4.3.3 Neurochemical affects of ECT.
4.4 Adverse Drug Reactions (ADRs)
4.4.1 Understanding of dose-related as distinct from idiosyncratic ADRs.
4.4.2 The major categories of ADRs associated with the main groups of
drugs used in psychiatry and those associated with appropriate
corrective action.
4.4.3 The importance of assessing risks and benefits for every individual
patient in relation to his medication. Risks and benefits of
psychotropic drugs in acute, short- and long-term use including
effects of withdrawal. Where appropriate, knowledge of official
Page 8 of 24
Page 9 of 24
Classification systems
5.1.1 a working knowledge of ICD and DSM classification and
diagnostic systems
5.1.2 WHO classification of impairments, disabilities, and handicaps.
A working knowledge of statementing for special needs
education.
5.2
Page 10 of 24
and
6.2
6.3
6.4
6.5
6.6
6.7
6.8
Page 11 of 24
Unipolar
Depression
Bipolar Disorder
Schizophrenia
Anxiety
Disorders
OCD
Hypochondriasis
Somatisation
Disorder
Dissociative
Disorders
Personality
Disorders
Organic
psychoses
Other
psychiatric
disorders
7.1.2.2
7.1.3.2
7.1.2.3
7.1.3.3
7.1.2.4
7.1.3.4
7.1.2.5
7.1.3.5
7.1.4.1
7.1.5.1
7.1.6.1
7.1.7.1
7.1.4.2
7.1.5.2
7.1.6.2
7.1.7.2
7.1.4.3
7.1.5.3
7.1.6.3
7.1.7.3
7.1.4.4
7.1.5.4
7.1.6.4
7.1.7.4
7.1.4.5
7.1.5.5
7.1.6.5
7.1.7.5
7.1.8.1
7.1.8.2
7.1.8.3
7.1.8.4
7.1.8.5
7.1.9.1
7.1.9.2
7.1.9.3
7.1.9.4
7.1.9.5
7.1.10.1
7.1.10.2
7.1.10.3
7.1.10.4
7.1.10.5
7.1.11.1
7.1.11.2
7.1.11.3
7.1.11.4
7.1.11.5
7.2
7.3
7.4
Emergency Psychiatry
7.4.1 all aspects of suicide, attempted suicide, and self harm
including risk assessment and risk management
7.4.2 knowledge
of
the
theory
and
practice
of
crisis
intervention/home treatment
7.4.3 differential diagnosis in emergency situations
7.4.4 treatment methods in emergency situations including the use
of appropriate legislation
Page 12 of 24
7.5
Anorexia
Nervosa
Bulimia
Nervosa
7.6
7.5.2.2
7.5.2.3
7.5.2.5
Psycho-sexual disorders
7.6.1 Non-Organic sexual dysfunction, including lack or loss of
sexual desire, lack of sexual enjoyment, and failure of genital
response
7.6.2 Gender Identity Disorders, including transsexualism and
transvestism
Page 13 of 24
7.5.2.4
8.2
8.3
8.4
8.5
Alzheimers
disease
Vascular
Dementia
Dementia
with Lewy
Bodies,
Parkinsons
Disease
Dementia
Frontotemporal
Dementia
Delirium
Depression
Bipolar
Disorder
Late
Life
Psychosis
Anxiety
Disorders
Substance
Misuse
Other
Mental
Disorders
8.5.2.2
8.5.2.3
8.5.2.4
8.5.2.5
8.5.3.1
8.5.3.2
8.5.3.3
8.5.3.4
8.5.3.5
8.5.4.1
8.5.4.2
8.5.4.3
8.5.4.4
8.5.4.5
8.5.5.1
8.5.6.1
8.5.7.1
8.5.5.2
8.5.6.2
8.5.7.2
8.5.5.3
8.5.6.3
8.5.7.3
8.5.5.4
8.5.6.4
8.5.7.4
8.5.5.5
8.5.6.5
8.5.7.5
8.5.8.1
8.5.8.2
8.5.8.3
8.5.8.4
8.5.8.5
8.5.9.1
8.5.9.2
8.5.9.3
8.5.9.4
8.5.9.5
8.5.10.1
8.5.10.2
8.5.10.3
8.5.10.4
8.5.10.5
8.5.11.1
8.5.11.2
8.5.11.3
8.5.10.4
8.5.11.5
Page 14 of 24
8.6
8.7
8.8
8.9
Page 15 of 24
9. PSYCHOTHERAPY
Trainees will be able to understand the principles and techniques of
psychosocial therapies sufficient to treat patients using brief and
supportive therapies and to know when and how to make a referral
that is indicated. Further to this they will be able to explain to a
patient prospective treatment if a referral is made. Thus they will be
able to:
State the characteristics and techniques of, and common indications for
psychodynamic
psychotherapy,
psychoanalysis,
supportive
psychotherapy, cognitive and behavioural therapies, group therapies,
couples and family therapies and psychoeducational interventions.
State the indications for and techniques of combining psychotherapy
with psychopharmacology
Describe
behavioural
interventions
(e.g.
relaxation
training,
assertiveness training, relapse prevention) and know for which
problems they are indicated or contraindicated.
The knowledge to be demonstrated will include a variety of
therapies and their cultural appropriateness:
9.1.1 Dynamic Psychotherapy
Development of psychodynamic concepts by Freud, the Neo-Freudians
Klein, Jung and Winnicott. An understanding of the following: therapeutic
alliance;
transference;
countertransference;
resistance;
negative
therapeutic reaction; acting out; interpretation; insight; working through
defence mechanisms. Indications for brief, long-term and supportive
psychotherapy. Therapeutic factors in groups.
9.2
Family Therapy
Influence of General Systems Theory. Different models of family therapy:
dynamic; structural; strategic; psychoeducational; behavioural. Goals of
treatment.
9.3
Cognitive-Behavioural Therapies
9.3.1 Behaviour Therapy. Understanding of systematic desensitisation,
operant conditioning, graded and cue exposure, habituation and social skills
training. How to conduct a functional analysis, formulate a treatment plan
and use measurement to assess change.
9.3.2 Cognitive Therapy. The cognitive model for non-psychotic
disorders. The importance of schema, negative automatic thoughts and
maladaptive assumptions. These will need to be considered in appropriate
cultural contexts.
9.4
9.5
Effectiveness of Psychotherapy
Difficulties in defining outcome, understanding of effect size and metaanalysis, specific and non-specific effects in psychotherapy and be aware of
contemporary guidelines. Research on outcomes in psychotherapy.
9.6
Group Therapy
Page 17 of 24
Page 18 of 24
Prevalence Aetiology
Attachment 10.8.1.1
10.8.1.2
disorders
Conduct
10.8.2.1
10.8.2.2
disorder
ADHD
10.8.3.1
10.8.3.2
Anxiety
10.8.4.1
10.8.4.2
disorders
including
OCD
Affective
10.8.5.1
10.8.5.2
Disorders
Psychosis
10.8.6.1
10.8.6.2
Eating
10.8.7.1
10.8.7.2
disorders
Autism
10.8.8.1
10.8.8.2
Spectrum
disorders
Substance
10.8.9.1
10.8.9.2
misuse
Tic
10.8.10.1
10.8.10.2
disorders
Other
10.8.11.1
10.8.11.2
childhood
disorders
10.9
10.8.2.4
10.8.2.5
10.8.3.3
10.8.4.3
10.8.3.4
10.8.4.4
10.8.3.5
10.8.4.5
10.8.5.3
10.8.5.4
10.8.5.5
10.8.6.3
10.8.7.3
10.8.6.4
10.8.7.4
10.8.6.5
10.8.7.5
10.8.8.3
10.8.8.4
10.8.8.5
10.8.9.3
10.8.9.4
10.8.9.5
10.8.10.3
10.8.10.4
10.8.10.5
10.8.11.3
10.8.11.4
10.8.11.5
10.10 Indications
and
contra-indications
for
interventions. Indications for in-patient care.
Page 19 of 24
different
treatment
11.2
11.3
11.4
Who uses which drugs and why; reasons for initiating and continuing
drug use; how to recognise drug use; the concept of problem drug
use; patterns of dependence on different drugs; detoxification
procedures for inpatients and outpatients. An understanding of
cultural factors in the use and abuse of drugs.
Basics of the
biological, psychological and socio-cultural explanations of drug and
alcohol dependence.
11.5
The interaction of drug and alcohol use with psychiatric illness. Dual
diagnosis and co-morbidity (classificatory systems). Recognition of
substance
misuse
related
medical,
psychiatric
and
social
complications and their impact on Public Health.
11.6
11.7
11.8
11.9
11.10
of
non-substance
addictive
Page 21 of 24
12 Forensic Psychiatry
12.1 Relationship between crime and mental disorder
12.1.1 Knowledge of the range of offences committed by mentally
disordered offenders. Specific crimes and their psychiatric relevance
particularly: homicide; other crimes of violence (including
infanticide); sex offences; arson; and criminal damage.
12.1.2 The relationship between specific mental disorders and crime:
substance misuse; epilepsy; schizophrenia; bipolar affective disorder;
neuro-developmental disorders; personality disorders.
12.1.3 Special syndromes: morbid jealousy, erotomania, Munchausen and
Munchausen by proxy.
12.1.4 Mental disorders and offending in special groups: young offenders;
female offenders; offenders from ethnic minorities; offenders who are
deaf or have other physical disabilities.
12.1.5 Effect of victimisation and vulnerability: anxiety states including
post-traumatic stress disorder; suggestibility; anger and aggressive
behaviour. Effect of compensation on presentation.
12.2 Psychiatry and the criminal justice system
12.2.1 The role of the psychiatrist is the assessment of mentally disordered
offenders: during arrest; prior to conviction; prior to sentencing.
12.2.2 Psychiatric defences: Fitness to plead; mutism and deafness;
criminal responsibility; diminished responsibility; amnesia and
automatism.
12.2.3 Psychiatric disposals following conviction.
12.2.4 Skills to write a court report in relation to a criminal case.
12.2.5 Skills to provide oral evidence in court as an expert witness and as
a professional witness.
12.3 Practicing psychiatry in a secure setting
12.3.1
The role of security in a therapeutic environment.
12.3.2
The essential components of a forensic service and the specific
patient needs and disabilities that can be assisted by such a service
provision
12.3.3 Knowledge of the prevalence of psychiatric disorder in prison
populations, suicide in prisoners, psychiatric treatment in prison
settings.
12.5.3 Risk management planning in forensic psychiatric practice
12.5.4 Managing mentally disordered offenders discharged into the
community
12.4 Human rights legislation as it effects patients and psychiatric
practice.
Page 22 of 24
13 Learning Disability
The topics suggested should complement those topics which will be covered in
other areas of psychiatry, particularly neuropsychiatry and child psychiatry.
13.1 Services
13.1.1 Normalisation and related social theories and their influence on
service development for people with a intellectual disability The change
from an institutional to an individualised, needs led approach.
13.1.2 The provision of specialist psychiatric services for people with
intellectual disability.
13.2.1 Epidemiology
The prevalence/incidence of intellectual disability in the general
population. The prevalence/incidence of superadded behavioural,
psychiatric and other impairments within this group. The factors which
might account to the observed high rates of psychiatric behavioural
disorders in this group.
13.2.2 Aetiology
Biological causes of intellectual disability, including genetic and
environmental effects, and the clinical characteristics of reasonably
common biological conditions associated with intellectual disability such as
Down Syndrome, fragile-X syndrome and foetal alcohol syndrome
The influence of psychological and social factors on intellectual and
emotional development in people with intellectual disability, including the
concept of secondary handicap.
13.3 Clinical
13.3.1 Assessment and communication with people with intellectual
disability.
13.3.2
The presentation and diagnosis of psychiatric illness and
behavioural disorder in people with intellectual disability, including
the concept of diagnostic overshadowing
13.3.3 Psychological methods of assessment and an understanding of
psychological theories as to the cause of problem behaviours. An
understanding of relevant behavioural modification techniques.
13.3.4 The application of psychiatric methods of treatment in intellectual
disability including psychotherapy, drug treatments, behaviour
therapy and cognitive therapy.
The application of a multidisciplinary approach to the management
of mental health problems in people with intellectual disability
13.3.5
Specific syndromes and their association with particular
psychiatric or behavioural disorders (behavioural phenotypes).
13.3.6 The impact of disability on the family and the psychological
consequences of having a child with a disability.
13.3.7 The assessment, management and treatment of offenders with
Intellectual disability
Page 23 of 24
Page 24 of 24